Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 0.24 Seriously?

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Nov 17, 2022 3:49pm

218 Views

Post# 35108225

RE:RE:RE:RE:RE:0.24 Seriously?

Just to be all positive, I had another thought around the science.

When they published the phase 1b patients we got more granular detail including that some of the patients had multiple tumours on the bladder and were still cured, one and done. In all the other CR data we have gotten we have never been told much about the specifics of the patients to date. Wouldn't it be cool if many of the CR patients had CR success despite multiple tumours and multiple prior treatments. It would mean more and makes things even more impressive. One can dream.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle